Peter G Noordzij Selected Research

Peter G Noordzij Research Topics

8	Frailty 01/2023 - 01/2020
5	Cardiovascular Diseases (Cardiovascular Disease) 02/2008 - 06/2007
4	Myocardial Ischemia (Ischemic Heart Diseases) 02/2008 - 10/2007
3	Myocardial Infarction 04/2022 - 11/2007
3	Hemorrhage 01/2022 - 01/2021
3	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 04/2015
3	Peripheral Arterial Disease 01/2020 - 06/2007
2	Inflammation (Inflammations) 11/2023 - 01/2018
2	Pneumonia (Pneumonitis) 04/2022 - 01/2017
2	Postoperative Hemorrhage 01/2022 - 01/2019
2	Heart Diseases (Heart Disease) 11/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 03/2016
2	Hypotension (Low Blood Pressure) 04/2017 - 04/2008
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2016 - 04/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2015 - 04/2008
2	Ischemia 02/2008 - 06/2007
1	COVID-19 04/2024
1	Iron Deficiencies 12/2023
1	Sepsis (Septicemia) 10/2023
1	Malnutrition (Nutritional Deficiencies) 01/2023
1	Renal Insufficiency (Renal Failure) 04/2022
1	Aneurysm (Aneurysms) 01/2022
1	Chronic Pain 01/2022
1	Rectal Neoplasms (Rectal Cancer) 12/2021
1	Hypertension (High Blood Pressure) 11/2021
1	Hernia (Hernias) 05/2010
1	Death (Near-Death Experience) 04/2008
1	Diabetes Mellitus 02/2008
1	Glucose Intolerance 02/2008
1	Abdominal Aortic Aneurysm 11/2007
1	Cardiac Arrhythmias (Arrythmia) 11/2007
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2007
1	Prediabetic State (Prediabetes) 01/2007

4	Troponin T (Troponin T1)IBA 01/2017 - 10/2007
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2021
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2007 - 06/2007
2	Oxygen (Dioxygen)IBA 02/2022 - 01/2021
2	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 01/2019
2	Urea (Carbamide)FDA LinkGeneric 11/2021 - 01/2021
2	Dobutamine FDA LinkGeneric 04/2008 - 06/2007
2	Glucose (Dextrose)FDA LinkGeneric 02/2008 - 01/2007
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 04/2024
1	IronIBA 12/2023
1	trans-crotonin (CTN)IBA 11/2023
1	Syntex adjuvant formulationIBA 01/2023
1	Advanced Glycation End ProductsIBA 01/2023
1	CreatinineIBA 11/2021
1	NitrogenIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	AlbuminsIBA 01/2021
1	Adenosine Diphosphate (ADP)IBA 01/2019
1	C-Reactive ProteinIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	omega-Chloroacetophenone (Mace)IBA 04/2008
1	TroponinIBA 02/2008
1	LDL CholesterolIBA 10/2007
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2007

4	Polypharmacy 01/2023 - 02/2020
4	Vascular Surgical Procedures 01/2020 - 10/2007
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 02/2022 - 04/2017
2	Length of Stay 04/2024 - 03/2016
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2021 - 04/2017
2	Therapeutics 01/2021 - 10/2007
2	Transcatheter Aortic Valve Replacement 01/2018 - 04/2015
1	Intravenous Administration 10/2023
1	Erythrocyte Transfusion 04/2022
1	Deep Hypothermia Induced Circulatory Arrest 01/2022
1	Blood Transfusion (Blood Transfusions) 01/2022
1	Chemoradiotherapy 12/2021
1	Radiotherapy 12/2021
1	Preoperative Exercise 11/2020
1	Cystectomy 01/2020
1	Endovascular Procedures 01/2020
1	Activities of Daily Living (ADL) 01/2020
1	Liver Transplantation 05/2010